COVID-19 Diagnostics Market (2024 - 2030) Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Kits, Services), By Sample Type, By Test Type, By Mode, By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation and Scope
                      1.2. Market Definitions
                          1.2.1. Information Analysis
                          1.2.2. Market Formulation & Data Visualization
                          1.2.3. Data Validation & Publishing
                      1.3. Research Assumptions
                      1.4. Information Procurement
                          1.4.1. Primary Research
                      1.5. Information or Data Analysis
                      1.6. Market Formulation & Validation
                      1.7. Market Model
                      1.8. Global Market: CAGR Calculation
                      1.9. Objective
                          1.9.1. Objective 1
                          1.9.2. Objective2
Chapter 2. Executive Summary
                      2.1. Market Snapshot
                      2.2. Segment Snapshot
                      2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent Market Outlook
                          3.1.2. Related/Ancillary Market Outlook
                      3.2. Market Dynamics
                          3.2.1. Market Driver Analysis
                              3.2.1.1. Increase in the incidence of coronavirus globally
                              3.2.1.2. North America
                              3.2.1.3. Europe
                              3.2.1.4. Asia Pacific
                              3.2.1.5. Latin America
                              3.2.1.6. Middle East and Africa
                              3.2.1.7. Increasing product approvals by regulatory agencies
                              3.2.1.8. Government initiatives toward mass testing
                              3.2.1.9. Paradigm shift toward POC testing
                          3.2.2. Market Restraint Analysis
                              3.2.2.1. Limited testing capacity
                              3.2.2.2. Low demand due to supply ratio of COVID-19 reagents
                          3.2.3. Market opportunity analysis
                              3.2.3.1. Potential emerging markets
                              3.2.3.2. Favorable reimbursement scenario
                              3.2.3.3. Increasing penetration of telehealth in the diagnosis of Covid-19
                          3.2.4. Market Challenge analysis
                              3.2.4.1. Challenges pertaining to COVID-19 testing in healthcare settings
                      3.3. Industry Analysis Tools
                          3.3.1. Porter’s Five Forces Analysis
                          3.3.2. PESTEL Analysis
                          3.3.3. COVID-19 Diagnostics: Company Position Analysis
                          3.3.4. COVID-19 Diagnostics: Healthcare Spending and Funding Scenario in Different Countries
                          3.3.4.1. U.S.
                              3.3.4.2. China
                              3.3.4.3. Brazil
                              3.3.4.4. Germany
                              3.3.4.5. Others
                          3.3.5. Effect on Swabs Market
                              3.3.5.1. Production shortage for viral transport media
                              3.3.5.2. Companies leading the viral transport media market
                              3.3.5.3. COPAN Diagnostics
                              3.3.5.4. PURITAN MEDICAL PRODUCTS
                              3.3.5.5. Becton, Dickinson and Company (BD)
                              3.3.5.6. Thermo Fisher Scientific
                              3.3.5.7. Other emerging companies
                          3.3.6. Pricing Analysis
Chapter 4. Product & Service Business Analysis
                      4.1. Segment Dashboard
                      4.2. COVID-19 Diagnostics Market: Product & Service Movement Analysis, USD Million, 2023 & 2030
                      4.3. Reagents & Kits
                          4.3.1. Reagents & Kits Market, 2020 - 2030 (USD Million)
                      4.4. Instruments
                          4.4.1. Instruments Market, 2020 - 2030 (USD Million)
                      4.5. Services
                          4.5.1. Services Market, 2020 - 2030 (USD Million)
Chapter 5. Sample Type Business Analysis
                      5.1. Segment Dashboard
                      5.2. COVID-19 Diagnostics Market: Sample Type Movement Analysis, USD Million, 2023 & 2030
                      5.3. Nasopharyngeal (NP) Swabs
                          5.3.1. Nasopharyngeal (NP) Swabs Tests Market, 2020 - 2030 (USD Million)
                      5.4. Oropharyngeal (OP) Swabs
                          5.4.1. Oropharyngeal (OP) Swabs Market, 2020 - 2030 (USD Million)
                      5.5. Nasal Swabs
                          5.5.1. Nasal Swabs Market, 2020 - 2030 (USD Million)
                      5.6. Blood
                          5.6.1. Blood Market, 2020 - 2030 (USD Million)
                      5.7. Others
                          5.7.1. Others Market, 2020 - 2030 (USD Million)
Chapter 6. Test Type Business Analysis
                      6.1. Segment Dashboard
                      6.2. COVID-19 Diagnostics Market: Test Type Movement Analysis, USD Million, 2023 & 2030
                      6.3. Molecular (PCR) Testing
                          6.3.1. Molecular (PCR) Testing Market, 2020 - 2030 (USD Million)
                      6.4. Antigen-based Testing
                          6.4.1. Antigen-based Testing Market, 2020 - 2030 (USD Million)
                      6.5. Antibody (Serology) Testing
                          6.5.1. Antibody (Serology) Testing Market, 2020 - 2030 (USD Million)
                      6.6. Others
                          6.6.1. Others Market, 2020 - 2030 (USD Million)
Chapter 7. Mode Business Analysis
                      7.1. Segment Dashboard
                      7.2. COVID-19 Diagnostics Market: Mode Movement Analysis, USD Million, 2023 & 2030
                      7.3. Point-of-Care (PoC) Testing
                          7.3.1. Point-of-Care (PoC) Testing Market, 2020 - 2030 (USD Million)
                      7.4. Non-Point-of-Care (Non-PoC) Testing
                          7.4.1. Non-Point-of-Care (Non-PoC) Testing Market, 2020 - 2030 (USD Million)
Chapter 8. End-use Business Analysis
                      8.1. Segment Dashboard
                      8.2. COVID-19 Diagnostics Market: End-use Movement Analysis, USD Million, 2023 & 2030
                      8.3. Laboratories
                          8.3.1. Laboratories Market, 2020 - 2030 (USD Million)
                      8.4. Hospitals
                          8.4.1. Hospitals Market, 2020 - 2030 (USD Million)
                      8.5. Diagnostic Centers and Clinics
                          8.5.1. Diagnostic Centers and Clinics Market, 2020 - 2030 (USD Million)
                      8.6. Others
                          8.6.1. Others Market, 2020 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
                      9.1. COVID-19 Diagnostics Market Share By Region, 2023 & 2030
                      9.2. North America
                          9.2.1. SWOT Analysis
                          9.2.2. North America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.2.3. U.S.
                              9.2.3.1. Key Country Dynamics
                              9.2.3.2. Competitive Scenario
                              9.2.3.3. Regulatory Framework
                              9.2.3.4. U.S. COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.2.4. Canada
                              9.2.4.1. Key Country Dynamics
                              9.2.4.2. Competitive Scenario
                              9.2.4.3. Regulatory Framework
                              9.2.4.4. Canada COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                      9.3. Europe
                          9.3.1. SWOT Analysis
                          9.3.2. Europe COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.3. UK
                              9.3.3.1. Key Country Dynamics
                              9.3.3.2. Competitive Scenario
                              9.3.3.3. Regulatory Framework
                              9.3.3.4. UK COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.4. Germany
                              9.3.4.1. Key Country Dynamics
                              9.3.4.2. Competitive Scenario
                              9.3.4.3. Regulatory Framework
                              9.3.4.4. Germany COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.5. France
                              9.3.5.1. Key Country Dynamics
                              9.3.5.2. Competitive Scenario
                              9.3.5.3. Regulatory Framework
                              9.3.5.4. France COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.6. Italy
                              9.3.6.1. Key Country Dynamics
                              9.3.6.2. Competitive Scenario
                              9.3.6.3. Regulatory Framework
                              9.3.6.4. Italy COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.7. Spain
                              9.3.7.1. Key Country Dynamics
                              9.3.7.2. Competitive Scenario
                              9.3.7.3. Regulatory Framework
                              9.3.7.4. Spain COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.8. Sweden
                              9.3.8.1. Key Country Dynamics
                              9.3.8.2. Competitive Scenario
                              9.3.8.3. Regulatory Framework
                              9.3.8.4. Sweden COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.9. Norway
                              9.3.9.1. Key Country Dynamics
                              9.3.9.2. Competitive Scenario
                              9.3.9.3. Regulatory Framework
                              9.3.9.4. Norway COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.3.10. Denmark
                              9.3.10.1. Key Country Dynamics
                              9.3.10.2. Competitive Scenario
                              9.3.10.3. Regulatory Framework
                              9.3.10.4. Denmark COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                      9.4. Asia Pacific
                          9.4.1. SWOT Analysis
                          9.4.2. Asia Pacific COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.3. Japan
                              9.4.3.1. Key Country Dynamics
                              9.4.3.2. Competitive Scenario
                              9.4.3.3. Regulatory Framework
                              9.4.3.4. Japan COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.4. China
                              9.4.4.1. Key Country Dynamics
                              9.4.4.2. Competitive Scenario
                              9.4.4.3. Regulatory Framework
                              9.4.4.4. China COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.5. India
                              9.4.5.1. Key Country Dynamics
                              9.4.5.2. Competitive Scenario
                              9.4.5.3. Regulatory Framework
                              9.4.5.4. India COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.6. Australia
                              9.4.6.1. Key Country Dynamics
                              9.4.6.2. Competitive Scenario
                              9.4.6.3. Regulatory Framework
                              9.4.6.4. Australia COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.7. Thailand
                              9.4.7.1. Key Country Dynamics
                              9.4.7.2. Competitive Scenario
                              9.4.7.3. Regulatory Framework
                              9.4.7.4. Thailand COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.4.8. South Korea
                              9.4.8.1. Key Country Dynamics
                              9.4.8.2. Competitive Scenario
                              9.4.8.3. Regulatory Framework
                              9.4.8.4. South Korea COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                      9.5. Latin America
                          9.5.1. SWOT Analysis
                          9.5.2. Latin America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.5.3. Brazil
                              9.5.3.1. Key Country Dynamics
                              9.5.3.2. Competitive Scenario
                              9.5.3.3. Regulatory Framework
                              9.5.3.4. Brazil COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.5.4. Mexico
                              9.5.4.1. Key Country Dynamics
                              9.5.4.2. Competitive Scenario
                              9.5.4.3. Regulatory Framework
                              9.5.4.4. Mexico COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.5.5. Argentina
                              9.5.5.1. Key Country Dynamics
                              9.5.5.2. Competitive Scenario
                              9.5.5.3. Regulatory Framework
                              9.5.5.4. Argentina COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                      9.6. MEA
                          9.6.1. SWOT Analysis
                          9.6.2. MEA COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.6.3. South Africa
                              9.6.3.1. Key Country Dynamics
                              9.6.3.2. Competitive Scenario
                              9.6.3.3. Regulatory Framework
                              9.6.3.4. South Africa COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.6.4. Saudi Arabia
                              9.6.4.1. Key Country Dynamics
                              9.6.4.2. Competitive Scenario
                              9.6.4.3. Regulatory Framework
                              9.6.4.4. Saudi Arabia COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.6.5. UAE
                              9.6.5.1. Key Country Dynamics
                              9.6.5.2. Competitive Scenario
                              9.6.5.3. Regulatory Framework
                              9.6.5.4. UAE COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
                          9.6.6. Kuwait
                              9.6.6.1. Key Country Dynamics
                              9.6.6.2. Competitive Scenario
                              9.6.6.3. Regulatory Framework
                              9.6.6.4. Kuwait COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                      10.1. Company Categorization
                      10.2. Strategy Mapping
                      10.3. Company Market Share Analysis, 2023
                      10.4. Company Profiles/Listing
                              10.4.1. F. Hoffmann-La Roche AG
                              10.4.1.1. Overview
                              10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.1.3. Product Benchmarking
                              10.4.1.4. Strategic Initiatives
                          10.4.2. Thermo Fisher Scientific, Inc.
                              10.4.2.1. Overview
                              10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.2.3. Product Benchmarking
                              10.4.2.4. Strategic Initiatives
                          10.4.3. PerkinElmer, Inc.
                              10.4.3.1. Overview
                              10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.3.3. Product Benchmarking
                              10.4.3.4. Strategic Initiatives
                          10.4.4. 1drop, Inc.
                              10.4.4.1. Overview
                              10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.4.3. Product Benchmarking
                              10.4.4.4. Strategic Initiatives
                          10.4.5. Veredus Laboratories
                              10.4.5.1. Overview
                              10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.5.3. Product Benchmarking
                              10.4.5.4. Strategic Initiatives
                          10.4.6. ADT Biotech SdnBhd
                              10.4.6.1. Overview
                              10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.6.3. Product Benchmarking
                              10.4.6.4. Strategic Initiatives
                          10.4.7. altona Diagnostics GmbH
                              10.4.7.1. Overview
                              10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.7.3. Product Benchmarking
                              10.4.7.4. Strategic Initiatives
                          10.4.8. bioMérieux SA
                              10.4.8.1. Overview
                              10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.8.3. Product Benchmarking
                              10.4.8.4. Strategic Initiatives
                          10.4.9. Neuberg Diagnostics
                              10.4.9.1. Overview
                              10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.9.3. Product Benchmarking
                              10.4.9.4. Strategic Initiatives
                          10.4.10. Abbott Laboratories
                              10.4.10.1. Overview
                              10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.10.3. Product Benchmarking
                              10.4.10.4. Strategic Initiatives
                          10.4.11. Luminex Corporation
                              10.4.11.1. Overview
                              10.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.11.3. Product Benchmarking
                              10.4.11.4. Strategic Initiatives
                          10.4.12. Laboratory Corporation of America Holdings
                              10.4.12.1. Overview
                              10.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.12.3. Product Benchmarking
                              10.4.12.4. Strategic Initiatives
                          10.4.13. Hologic Inc.
                              10.4.13.1. Overview
                              10.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.13.3. Product Benchmarking
                              10.4.13.4. Strategic Initiatives
                          10.4.14. Quest Diagnostics, Inc.
                              10.4.14.1. Overview
                              10.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.14.3. Product Benchmarking
                              10.4.14.4. Strategic Initiatives
                          10.4.15. Quidel Corporation
                              10.4.15.1. Overview
                              10.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.15.3. Product Benchmarking
                              10.4.15.4. Strategic Initiatives
                          10.4.16. ALDATU BIOSCIENCES
                              10.4.16.1. Overview
                              10.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.16.3. Product Benchmarking
                              10.4.16.4. Strategic Initiatives
                          10.4.17. Mylab Discovery Solutions Pvt. Ltd.
                              10.4.17.1. Overview
                              10.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.17.3. Product Benchmarking
                              10.4.17.4. Strategic Initiatives
                          10.4.18. Danaher Corporation
                              10.4.18.1. Overview
                              10.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.18.3. Product Benchmarking
                              10.4.18.4. Strategic Initiatives
                          10.4.19. Cepheid
                              10.4.19.1. Overview
                              10.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.19.3. Product Benchmarking
                              10.4.19.4. Strategic Initiatives
                          10.4.20. Beckman Coulter, Inc.
                              10.4.20.1. Overview
                              10.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              10.4.20.3. Product Benchmarking
                              10.4.20.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Incidence rate of COVID-19 in North America
Table 4 Incidence rate of COVID-19 in Europe
Table 5 Incidence rate of COVID-19 in Asia Pacific
Table 6 Incidence rate of COVID-19 in Latin America
Table 7 Incidence rate of COVID-19 in Middle East and Africa
Table 8 Specimen collection and storage for COVID-19 testing
Table 9 Different COVID-19 diagnostic tests based on different technologies
Table 10 Global COVID-19 Diagnostics Market, By region, 2020 - 2030 (USD Million)
Table 11 Global COVID-19 Diagnostics Market, By product & service, 2020 - 2030 (USD Million)
Table 12 Global COVID-19 Diagnostics Market, By sample type, 2020 - 2030 (USD Million)
Table 13 Global COVID-19 Diagnostics Market, By test type, 2020 - 2030 (USD Million)
Table 14 Global COVID-19 Diagnostics Market, By mode, 2020 - 2030 (USD Million)
Table 15 Global COVID-19 Diagnostics Market, By end use, 2020 - 2030 (USD Million)
Table 16 North America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 17 North America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 18 North America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 19 North America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 20 North America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 21 U.S. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 22 U.S. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 23 U.S. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 24 U.S. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 25 U.S.. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 26 Canada COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 27 Canada COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 28 Canada COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 29 Canada COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 30 Canada COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million).
Table 31 Europe America COVID-19 Diagnostics Market, by country, 2020-2030, (USD Million)
Table 32 Europe COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 33 Europe COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 34 Europe COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 35 Europe COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 36 Europe COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million))
Table 37 U.K. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 38 U.K. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 39 U.K. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 40 U.K. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 41 U.K. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 42 Germany COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 43 Germany COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 44 Germany COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 45 Germany COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 46 Germany COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 47 France COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 48 France COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 49 France COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 50 France COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 51 France COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 52 Italy COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 53 Italy COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 54 Italy COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 55 Italy COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 56 Italy COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 57 Spain COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 58 Spain COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 59 Spain COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 60 Spain COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 61 Spain COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 62 Sweden COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 63 Sweden COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 64 Sweden COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 65 Sweden COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 66 Sweden COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 67 Norway COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 68 Norway COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 69 Norway COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 70 Norway COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 71 Norway COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 72 Denmark COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 73 Denmark COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 74 Denmark COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 75 Denmark COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 76 Denmark COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 77 Asia Pacific America COVID-19 Diagnostics Market, by country, 2020-2030, (USD Million)
Table 78 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 79 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 80 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 81 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 82 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 83 China COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 84 China COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 85 China COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 86 China COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 87 China COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 88 India COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 89 India COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 90 India COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 91 India COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 92 India COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 93 Japan COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 94 Japan COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 95 Japan COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 96 Japan COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 97 Japan COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 98 South Korea COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 99 South Korea COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 100 South Korea COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 101 South Korea COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 102 South Korea COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 103 Australia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 104 Australia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 105 Australia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 106 Australia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 107 Australia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 108 Thailand COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 109 Thailand COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 110 Thailand COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 111 Thailand COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 112 Thailand COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 113 Latin America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 114 Latin America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 115 Latin America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 116 Latin America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 117 Latin America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 118 Brazil COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 119 Brazil COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 120 Brazil COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 121 Brazil COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 122 Brazil COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 123 Mexico COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 124 Mexico COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 125 Mexico COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 126 Mexico COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 127 Mexico COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 128 Argentina COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 129 Argentina COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 130 Argentina COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 131 Argentina COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 132 Argentina COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 133 MEA COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 134 MEA COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 135 MEA COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 136 MEA COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 137 MEA COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 138 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 139 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 140 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 141 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 142 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 143 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 144 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 145 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 146 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 147 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 148 UAE COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 149 UAE COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 150 UAE COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 151 UAE COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 152 UAE COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)
Table 153 Kuwait COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2030 (USD Million)
Table 154 Kuwait COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2030 (USD Million)
Table 155 Kuwait COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2030 (USD Million)
Table 156 Kuwait COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2030 (USD Million)
Table 157 Kuwait COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2030 (USD Million)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 COVID-19 Diagnostics Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Distribution of cases, as of 16th July 2020
Fig. 10 Distribution of cases, as of 4th June 2020
Fig. 11 Total number of cases in North America (1st March 2020-1st June 2020)
Fig. 12 Total number of cases in Europe (1st March 2020-1st June 2020)
Fig. 13 Total number of cases in Asia Pacific (excluding Oceania) (1st March 2020-1st June 2020)
Fig. 14 Total number of cases in Latin American countries (1st March 2020-1st June 2020)
Fig. 15 Total number of cases in South Africa (1st March 2020-1st June 2020)
Fig. 16 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 17 Company Position Analysis
Fig. 18 Healthcare expenditure in China, 2018-2023
Fig. 19 Healthcare expenditure in Brazil, 2018-2023
Fig. 20 Market Opportunity Relevance Analysis (Current & Future Impact)
Fig. 21 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 22 Penetration & Growth Prospect Mapping
Fig. 23 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 24 Porter’s Five Forces Analysis
Fig. 25 COVID-19 diagnostics market: Product & service outlook and key takeaways
Fig. 26 COVID-19 diagnostics market: Product & service movement analysis
Fig. 27 Global COVID-19 diagnostics reagents & kits market, 2020 - 2030 (USD Million)
Fig. 28 Global COVID-19 diagnostics instruments market, 2020 - 2030 (USD Million)
Fig. 29 Global COVID-19 diagnostic services market, 2020 - 2030 (USD Million)
Fig. 30 COVID-19 diagnostics market: Sample type outlook and key takeaways
Fig. 31 COVID-19 diagnostics market: Sample type movement analysis
Fig. 32 Global COVID-19 diagnostics nasopharyngeal swabs market, 2020 - 2030 (USD Million)
Fig. 33 Global COVID-19 diagnostics oropharyngeal swabs market, 2020 - 2030 (USD Million)
Fig. 34 Global COVID-19 diagnostics nasal swabs market, 2020 - 2030 (USD Million)
Fig. 35 Global COVID-19 diagnostics blood market, 2020 - 2030 (USD Million)
Fig. 36 Global COVID-19 diagnostics other samples market, 2020 - 2030 (USD Million)
Fig. 37 COVID-19 diagnostics market: Test type outlook and key takeaways
Fig. 38 COVID-19 diagnostics market: Test type movement analysis
Fig. 39 Global COVID-19 molecular (PCR) testing market, 2020 - 2030 (USD Million)
Fig. 40 Global COVID-19 antigen-based testing market, 2020 - 2030 (USD Million)
Fig. 41 Global COVID-19 antibody (Serology) testing market, 2020 - 2030 (USD Million)
Fig. 42 Global COVID-19 diagnostics other tests market, 2020 - 2030 (USD Million)
Fig. 43 COVID-19 diagnostics market: Mode outlook and key takeaways
Fig. 44 COVID-19 diagnostics market: Mode movement analysis
Fig. 45 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2030 (USD Million)
Fig. 46 Global COVID-19 non-Point-of-Care (Non-PoC) testing market, 2020 - 2030 (USD Million)
Fig. 47 COVID-19 diagnostics market: End-use outlook and key takeaways
Fig. 48 COVID-19 diagnostics market: End-use movement analysis
Fig. 49 Global laboratories-based COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 50 Global hospitals-based COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 51 Global diagnostic centers and clinics-based COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 52 Global other end-uses-based COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 53 Regional Marketplace: Key Takeaways
Fig. 54 Regional Outlook, 2023 & 2030
Fig. 55 Regional Market Dashboard
Fig. 56 Regional Market Place: Key Takeaways
Fig. 57 North America
Fig. 58 North America COVID-19 Diagnostics Market Estimates and Forecast, 2020 - 2030 (USD Million)
Fig. 59 U.S. Key Country Dynamics
Fig. 60 U.S. COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 61 Canada Key Country Dynamics
Fig. 62 Canada COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 63 Europe COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 64 UK Key Country Dynamics
Fig. 65 UK COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 66 Germany Key Country Dynamics
Fig. 67 Germany COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 68 France Key Country Dynamics
Fig. 69 France COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 70 Italy Key Country Dynamics
Fig. 71 Italy COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 72 Spain Key Country Dynamics
Fig. 73 Spain COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 74 Sweden Key Country Dynamics
Fig. 75 Sweden COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 76 Norway Key Country Dynamics
Fig. 77 Norway COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 78 Denmark Key Country Dynamics
Fig. 79 Denmark COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 80 Asia Pacific COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 81 Japan Key Country Dynamics
Fig. 82 Japan COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 83 China Key Country Dynamics
Fig. 84 China COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 85 India Key Country Dynamics
Fig. 86 India COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 87 Australia Key Country Dynamics
Fig. 88 Australia COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 89 Thailand Key Country Dynamics
Fig. 90 Thailand COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 91 South Korea Key Country Dynamics
Fig. 92 South Korea COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 93 Latin America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 94 Brazil Key Country Dynamics
Fig. 95 Brazil America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 96 Mexico Key Country Dynamics
Fig. 97 Mexico America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 98 Argentina Key Country Dynamics
Fig. 99 Argentina America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 100 Middle East and Africa America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 101 South Africa Key Country Dynamics
Fig. 102 South Africa America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 103 Saudi Arabia Key Country Dynamics
Fig. 104 Saudi Arabia America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 105 UAE Key Country Dynamics
Fig. 106 UAE America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 107 Kuwait Key Country Dynamics
Fig. 108 Kuwait America COVID-19 Diagnostics Market, 2020 - 2030 (USD Million)
Fig. 109 Strategy Mapping